1.
Sverdloff CE, Marcondes Rezende V, Rebelo Galvinas PA, Araújo Pinto G, Nerath Bonanato L, Bastos Canton Pacheco F. Bioequivalence/bioavailability study of a new formulation of imatinib mesylate 100 mg coated tablets versus Glivec® in Brazilian healthy male volunteers in fed state. Rev. Bras. Cancerol. [Internet]. 2023 Dec. 14 [cited 2024 May 18];69(4):e-154060. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/4060